The myeloid-restricted receptor CD33 (Siglec-3) is a sialic acid-binding inhibitory receptor that dampens microglial phagocytosis of amyloid-β through the ITIM-mediated recruitment of SHP- 1/SHP-2. Although CD33 is a known genetic risk factor for late-onset Alzheimer’s disease (LOAD), how environmental neuroinflammatory triggers, neuronal sialoglycan availability, and variation within the CD33 V-set Ig domain jointly modulate this axis remains poorly defined. In human HMC3 microglial cells, the endocrine disruptor bisphenol-A and bacterial LPS significantly upregulated CD33 and IL-1β, while TREM2 expression remains unaffected, identifying inflammatory states associated with increased CD33 expression. In differentiating SH-SY5Y neurons, the sialyltransferases ST3GAL5 and ST3GAL2, responsible for GM3/GD3 ganglioside synthesis, were strongly induced upon retinoic acid and BDNF treatment, supporting neuronal availability of CD33 ligands. In PMA-differentiated THP-1 macrophages, exposure to the disialoganglioside GT1b modulated SYK phosphorylation, consistent with the ability of macrophage-like cells to translate ganglioside engagement into intracellular signaling. Parallel computational modeling of four V-set Ig domain missense variants (the LOAD-enriched rs2455069 p.R69G, together with F118L, R119W, and Y127H selected from ClinVar/gnomAD) were explored in silico (structural prediction and docking). The analysis identified R91 as a major alternative binding site to the canonical R119 across all variants and revealed variant-specific effects on binding-pocket conformation, while confocal immunofluorescence on transiently transfected HEK293 cells showed that R69G variant does not impair CD33 surface expression. Together, these data delineate a multi-scale framework in which inflammatory stimuli, neuronal sialoglycan availability, and CD33 V-set variation converge on the CD33 axis relevant to LOAD pathogenesis.

The CD33-ganglioside axis in late-onset Alzheimer’s disease: from environmental triggers to structural variants / Carrese, A.M., Bosso, A., Gaglione, R., Arciello, A., Hay Mele, B., Vitale, E., Donizetti, A.. - (2026). (9th Brainstorming Research Assembly For Young Neuroscientist ).

The CD33-ganglioside axis in late-onset Alzheimer’s disease: from environmental triggers to structural variants

Anna Maria Carrese
Primo
;
Andrea Bosso;Angela Arciello;Bruno Hay Mele;Aldo Donizetti
Ultimo
2026

Abstract

The myeloid-restricted receptor CD33 (Siglec-3) is a sialic acid-binding inhibitory receptor that dampens microglial phagocytosis of amyloid-β through the ITIM-mediated recruitment of SHP- 1/SHP-2. Although CD33 is a known genetic risk factor for late-onset Alzheimer’s disease (LOAD), how environmental neuroinflammatory triggers, neuronal sialoglycan availability, and variation within the CD33 V-set Ig domain jointly modulate this axis remains poorly defined. In human HMC3 microglial cells, the endocrine disruptor bisphenol-A and bacterial LPS significantly upregulated CD33 and IL-1β, while TREM2 expression remains unaffected, identifying inflammatory states associated with increased CD33 expression. In differentiating SH-SY5Y neurons, the sialyltransferases ST3GAL5 and ST3GAL2, responsible for GM3/GD3 ganglioside synthesis, were strongly induced upon retinoic acid and BDNF treatment, supporting neuronal availability of CD33 ligands. In PMA-differentiated THP-1 macrophages, exposure to the disialoganglioside GT1b modulated SYK phosphorylation, consistent with the ability of macrophage-like cells to translate ganglioside engagement into intracellular signaling. Parallel computational modeling of four V-set Ig domain missense variants (the LOAD-enriched rs2455069 p.R69G, together with F118L, R119W, and Y127H selected from ClinVar/gnomAD) were explored in silico (structural prediction and docking). The analysis identified R91 as a major alternative binding site to the canonical R119 across all variants and revealed variant-specific effects on binding-pocket conformation, while confocal immunofluorescence on transiently transfected HEK293 cells showed that R69G variant does not impair CD33 surface expression. Together, these data delineate a multi-scale framework in which inflammatory stimuli, neuronal sialoglycan availability, and CD33 V-set variation converge on the CD33 axis relevant to LOAD pathogenesis.
2026
The CD33-ganglioside axis in late-onset Alzheimer’s disease: from environmental triggers to structural variants / Carrese, A.M., Bosso, A., Gaglione, R., Arciello, A., Hay Mele, B., Vitale, E., Donizetti, A.. - (2026). (9th Brainstorming Research Assembly For Young Neuroscientist ).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1074116
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact